Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Liver Cancer is Scopus-indexed (Q1, CiteScore 17), WoS SCIE, DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1664-5553Verify ISSN ↗2235-1795Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 26 / 428 | 94th | Q1 |
| Hepatology | 8 / 88 | 91st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 17.
Liver Cancer is Q1 in Oncology (rank 26 of 428) and Q1 in Hepatology (rank 8 of 88), by CiteScore 2025.
Liver Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.334, quartile Q1, with an H-index of 69.
The publisher lists an article processing charge of about US$3,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Liver Cancer is published by S. Karger AG. Its print ISSN is 1664-5553 and its online ISSN is 2235-1795.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Liver Cancer has an h-index of 82 and a 2-year mean of 5.19 citations per paper (OpenAlex). Its Scopus CiteScore is 17, quartile Q1. On 2-year citations it ranks #55 of 424 Scopus journals in Oncology.
Liver Cancer published 84 papers in 2025; its busiest recent year was 2021 with 99. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from Japan (27.3%), China (26.2%) and South Korea (10.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.